ONCOLYTICS BIOTECH INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ONCOLYTICS BIOTECH INC. (ONCY) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 34.06 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- ONCOLYTICS BIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 34.06M shares, a 44.83% increase year-over-year.
- ONCOLYTICS BIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 30.40M shares, a 93.58% increase year-over-year.
- ONCOLYTICS BIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 23.52M shares.
- ONCOLYTICS BIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 15.70M shares.
- ONCOLYTICS BIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 30.48M shares, a 88.16% increase from fiscal 2024.
- ONCOLYTICS BIOTECH INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 16.20M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|
| 2026-06-30 | 34.06M shares 10-Q · filed 2026-08-12 | 34.06M shares 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 30.40M shares 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | 30.48M shares 10-K · filed 2026-03-30 | ||
| 2025-06-30 | 23.52M shares 10-Q · filed 2026-08-12 | 23.52M shares 10-Q · filed 2026-08-12 | |
| 2025-03-31 | 15.70M shares 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | 16.20M shares 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |